HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Koga Selected Research

Progressive Bulbar Palsy (Fazio Londe Syndrome)

6/2002Anti-GT1a IgG in Guillain-Barré syndrome.
5/2001Antecedent symptoms in Guillain-Barré syndrome: an important indicator for clinical and serological subgroups.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Koga Research Topics

Disease

19Guillain-Barre Syndrome
01/2007 - 02/2000
9Infections
05/2008 - 01/2000
5Schizophrenia (Dementia Praecox)
07/2015 - 07/2005
5Ophthalmoplegia (External Ophthalmoplegia)
08/2006 - 05/2001
5Neoplasms (Cancer)
04/2004 - 02/2000
4Stroke (Strokes)
01/2020 - 12/2009
4Obesity
09/2013 - 03/2000
4Miller Fisher Syndrome (Fisher Syndrome)
05/2008 - 08/2000
3Diabetes Mellitus
09/2011 - 05/2000
3Paralysis (Palsy)
11/2006 - 08/2001
2Ischemic Stroke
01/2020 - 12/2009
2Hyperuricemia
12/2009 - 04/2009
2Insulin Resistance
04/2009 - 05/2000
2Encephalitis (Encephalitis, Rasmussen)
05/2008 - 08/2006
2Atherosclerosis
12/2005 - 06/2004
2Ataxia (Dyssynergia)
11/2005 - 11/2001
2Hypogonadism (Hypergonadotropic Hypogonadism)
05/2005 - 11/2002
2Demyelinating Diseases (Demyelinating Disease)
03/2005 - 10/2002
2Hypertension (High Blood Pressure)
06/2004 - 03/2001
2Glucose Intolerance
06/2004 - 05/2000
2Progressive Bulbar Palsy (Fazio Londe Syndrome)
06/2002 - 05/2001
2Enteritis
11/2001 - 08/2000
2Psoriasis (Pustulosis Palmaris et Plantaris)
06/2001 - 06/2001
2Diarrhea
05/2001 - 08/2000
1Hypophosphatasia
02/2022
1Hypercalcemia (Milk Alkali Syndrome)
05/2021
1Osteolysis
05/2021
1Atrial Fibrillation
01/2020
1Alzheimer Disease (Alzheimer's Disease)
07/2015
1Mental Disorders (Mental Disorder)
07/2015
1Tay-Sachs Disease
01/2015
1Substance-Related Disorders (Drug Abuse)
01/2014
1Alcoholism (Alcohol Abuse)
01/2014
1Feeding and Eating Disorders (Eating Disorder)
01/2014
1Chronic Pain
01/2014
1Hepatitis
09/2013
1Chronic Hepatitis B
09/2013
1Coinfection
09/2013
1Tardive Dyskinesia
02/2013
1Cerebral Hemorrhage
08/2012
1Progressive Multifocal Leukoencephalopathy
08/2012
1Arterial Occlusive Diseases (Arterial Occlusive Disease)
12/2009
1Gout
04/2009
1Inflammation (Inflammations)
12/2005
1Autoimmune Diseases (Autoimmune Disease)
12/2005

Drug/Important Bio-Agent (IBA)

13Immunoglobulin G (IgG)IBA
05/2008 - 01/2001
11AntibodiesIBA
01/2007 - 02/2000
9GangliosidesIBA
01/2007 - 03/2000
4Peptides (Polypeptides)IBA
07/2015 - 07/2000
4Glucose (Dextrose)FDA LinkGeneric
12/2009 - 05/2000
4AutoantibodiesIBA
05/2008 - 05/2005
4C-Reactive ProteinIBA
12/2005 - 09/2000
3Proteins (Proteins, Gene)FDA Link
07/2015 - 01/2007
3Tissue Plasminogen Activator (Alteplase)FDA Link
03/2014 - 12/2009
3EpitopesIBA
11/2006 - 08/2000
3ganglioside M1b (GM1b)IBA
08/2006 - 03/2000
3Amantadine (Aman)FDA LinkGeneric
03/2005 - 10/2000
3CytokinesIBA
10/2001 - 04/2001
2NucleotidesIBA
02/2022 - 01/2000
2Antipsychotic Agents (Antipsychotics)IBA
02/2013 - 07/2005
2Indicators and Reagents (Reagents)IBA
09/2011 - 05/2001
2Estrogens (Estrogen)FDA Link
04/2009 - 03/2000
2Ethanol (Ethyl Alcohol)IBA
04/2009 - 02/2000
2Intravenous Immunoglobulins (IVIG)FDA Link
06/2004 - 01/2001
2AntigensIBA
04/2004 - 09/2001
2Messenger RNA (mRNA)IBA
02/2003 - 09/2001
1N- (4'- fluorobutyrophenone)- 4- (4- chlorophenyl)pyridinium (HPP(+))IBA
02/2022
1Alkaline PhosphataseIBA
05/2021
1Interleukin-2 Receptors (IL 2 Receptor)IBA
05/2021
1Parathyroid Hormone-Related ProteinIBA
05/2021
1Vitamin DFDA LinkGeneric
05/2021
1Parathyroid Hormone (Parathormone)IBA
05/2021
1Vitamin KFDA Link
01/2020
1N(4)-oleylcytosine arabinosideIBA
01/2020
1AnticoagulantsIBA
01/2020
1Amyloid (Amyloid Fibrils)IBA
07/2015
1G(M2) Ganglioside (Ganglioside GM2)IBA
01/2015
1Pharmaceutical PreparationsIBA
01/2015
1Opioid Analgesics (Opioids)IBA
01/2014
1Analgesics (Analgesic Drugs)IBA
01/2014
1Methamphetamine (Desoxyn)FDA LinkGeneric
01/2014
1Morphine (MS Contin)FDA LinkGeneric
01/2014
1Fentanyl (Sublimaze)FDA LinkGeneric
01/2014
1beta-2 Adrenergic ReceptorsIBA
09/2013
1Antihypertensive Agents (Antihypertensives)IBA
08/2012
1Mefloquine (Lariam)FDA LinkGeneric
08/2012
1AlbuminsIBA
09/2011
1Progestins (Progestagens)IBA
04/2009
1Uric Acid (Urate)IBA
04/2009
1NetrinsIBA
04/2008
1Phosphotransferases (Kinase)IBA
06/2007
1EnzymesIBA
06/2007
1GTP-Binding Proteins (G-Protein)IBA
01/2007
1Neuregulin-1 (Neuregulin 1)IBA
01/2007
1IV(4)-galactosyl-N-acetylganglioside GD1aIBA
08/2006

Therapy/Procedure

5Therapeutics
08/2012 - 01/2001
2Intravenous Administration
03/2014 - 06/2000
2Immunotherapy
02/2003 - 09/2001
1Highly Active Antiretroviral Therapy (HAART)
09/2013
1Hysterectomy
04/2009